Patrick Vermersch
Overview
Explore the profile of Patrick Vermersch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
224
Citations
4555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Helme A, Kalra D, Brichetto G, Peryer G, Vermersch P, Weiland H, et al.
Front Immunol
. 2025 Mar;
16:1487709.
PMID: 40034708
Artificial intelligence (AI) can play a vital role in achieving a shift towards predictive, preventive, and personalized medicine, provided we are guided by the science with and of patient input....
2.
De Seze J, Labauge P, Liblau R, Martinez M, Moreau T, Suchet L, et al.
Adv Ther
. 2025 Feb;
PMID: 39969782
Introduction: Dimethyl fumarate (DMF) has demonstrated a favorable benefit-risk profile in patients with relapsing-remitting multiple sclerosis (RRMS). Some patients may develop lymphopenia on DMF; therefore, LymphoTEC evaluated absolute lymphocyte count...
3.
Wiendl H, Barkhof F, Montalban X, Achiron A, Derfuss T, Chan A, et al.
Front Immunol
. 2025 Feb;
16:1512189.
PMID: 39963134
Background And Objectives: Cladribine tablets (CladT) represent an effective immune reconstitution therapy, administered in short treatment courses over two consecutive years. To better understand the amplitude of immune changes, we...
4.
Vermersch P, Gold R, Bar-Or A, Cree B, Fox R, Giovannoni G, et al.
Mult Scler Relat Disord
. 2025 Jan;
94:106259.
PMID: 39847856
Background: People with MS show abnormal thinning of the retinal layers, which is associated with clinical disability and brain atrophy, and is a potential surrogate marker of neurodegeneration and treatment...
5.
Donze C, Mekies C, Paillot G, Vermersch P, Montagu G, Brechenmacher L, et al.
Mult Scler Relat Disord
. 2024 Oct;
92:105925.
PMID: 39423727
Background: In multiple sclerosis (MS), the measure of the loss of autonomy appears to be particularly relevant to provide adapted and personalized responses to improve the quality of care in...
6.
Montalban X, Vermersch P, Arnold D, Bar-Or A, Cree B, Cross A, et al.
Lancet Neurol
. 2024 Sep;
23(11):1119-1132.
PMID: 39307151
Background: Evobrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, has shown preliminary efficacy in people with relapsing multiple sclerosis in a phase 2 trial. Here, we aimed to compare the safety...
7.
Comi G, Dalla Costa G, Stankoff B, Hartung H, Soelberg Sorensen P, Vermersch P, et al.
Nat Rev Neurol
. 2024 Sep;
20(10):573-586.
PMID: 39251843
Progressive multiple sclerosis poses a considerable challenge in the evaluation of disease progression and treatment response owing to its multifaceted pathophysiology. Traditional clinical measures such as the Expanded Disability Status...
8.
Praet J, Anderhalten L, Comi G, Horakova D, Ziemssen T, Vermersch P, et al.
Front Immunol
. 2024 Sep;
15:1446748.
PMID: 39224590
Multiple sclerosis (MS) is a devastating immune-mediated disorder of the central nervous system resulting in progressive disability accumulation. As there is no cure available yet for MS, the primary therapeutic...
9.
Zaratin P, Samadzadeh S, Seferoglu M, Ricigliano V, Silva J, Tunc A, et al.
Front Neurol
. 2024 Jul;
15:1407257.
PMID: 38974689
Significant advancements have been achieved in delineating the progress of the Global PROMS (PROMS) Initiative. The PROMS Initiative, a collaborative endeavor by the European Charcot Foundation and the Multiple Sclerosis...
10.
Lin T, Motamedi S, Asseyer S, Chien C, Saidha S, Calabresi P, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Jun;
11(5):e200269.
PMID: 38941572
Background And Objectives: Retinal optical coherence tomography (OCT) provides promising prognostic imaging biomarkers for future disease activity in multiple sclerosis (MS). However, raw OCT-derived measures have multiple dependencies, supporting the...